Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance
Clinical trial NCT00582166 · TERMINATED
Trial details
- NCT number
- NCT00582166
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-25
- Primary completion
- 2013-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.